Skip to content

Microarray-based genomic analysis for cancer-associated genetic alterations (e.g., tumor DNA from plasma)

Published: August 9, 2026Updated: August 16, 2026

This test examines small amounts of DNA from your blood to identify specific genetic changes that may be linked to certain cancers, such as those in the breast, prostate, or lung.

Quick summary

["Helps detect cancer-related genetic mutations that may influence treatment options."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
62343-9
Short code
CMA # change pnl Microarray
Synonyms
CMA # change pnl Microarray
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
microarray
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test uses a specialized microarray platform to analyze circulating tumor DNA (ctDNA) in your blood plasma. It looks for known genetic mutations or alterations that are commonly found in tumors of specific cancers, such as those in the breast, prostate, or lung. These genetic changes can help doctors determine if cancer is present, assess its spread, or guide personalized treatment decisions.

How the Test Works

A small blood sample is drawn and processed to extract DNA. This DNA is then analyzed using a microarray that contains probes targeting known cancer-related genetic sequences. The test detects whether these sequences are present in abnormal amounts, indicating possible cancer-related genetic alterations.

Why It Might Be Ordered

Your healthcare provider may recommend this test if you have a history of cancer, are at high risk for certain cancers, or are undergoing treatment to monitor for recurrence or progression. It can also be used to help select targeted therapies based on genetic findings.

What to Expect Before the Test

No special preparation is typically required, but you may need to fast for a few hours before the blood draw if instructed by your doctor. Wear comfortable clothing and plan to rest for a short time afterward, as you might feel lightheaded.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Frequently asked questions

What does this test tell me about my cancer risk or treatment options?
This test looks for specific genetic changes in your blood that may be linked to certain cancers. It does not directly measure your overall cancer risk but can help identify if cancer-related genetic mutations are present, which may guide treatment decisions if cancer is already diagnosed.
Will I need to do anything special before this test?
No special preparation is usually needed, but follow any specific instructions your doctor provides. You may need to fast for a short period before the blood draw if required.
How long will it take to get my results?
Results are typically available within a few days to a couple of weeks, depending on the laboratory and complexity of the test. Your doctor will discuss the findings with you during a follow-up visit.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy